Athersys completes patient enrollment for Phase I study of MultiStem Pharmaceutical Business Review Athersys, a biopharmaceutical company, has completed patient enrollment for its Phase I study of MultiStem for Hematopoietic Stem Cell Transplant Support in patients being treated for leukemia or other blood born cancers. ... Athersys Confirms Completion of Patient Enrollment for Its Phase I Study of ... Athersys Completes Enrollment In Repeat Dose Study Of MultiStem Athersys Confirms Completion of Patient Enrollment for Its Phase I Study of ... |
